Back
Akero Therapeutics Stock Price Chart

AI is creating a new wealth gap NOW [Here's what you need to do today]
Click here
Buy
71
AKRO
Akero Therapeutics
Last Price:
52.46
Seasonality Move:
28.46%
7 Day Trial
ALL ACCESS PASS
$
7

The U.S. Government Just Invested $140 Million In WHAT?
And he shows you exactly how to take advantage right here, starting today.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKRO is experiencing slight selling pressure.
Akero Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 49.59 | Buy |
20-day SMA: | 47.06 | Buy |
50-day SMA: | 44.02 | Buy |
200-day SMA: | 40.68 | Buy |
8-day EMA: | 50.1 | Buy |
20-day EMA: | 47.78 | Buy |
50-day EMA: | 45.53 | Buy |
200-day EMA: | 39.27 | Buy |
Akero Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.96 | Buy |
Relative Strength Index (14 RSI): | 67.52 | Buy |
Chaikin Money Flow: | -176314 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (44.13 - 49.81) | Buy |
Bollinger Bands (100): | (40.3 - 48.16) | Buy |
Akero Therapeutics Technical Analysis
May-26 | May-30 | May-31 | Jun-1 | Jun-2 | Jun-5 | Jun-6 | Jun-7 | Jun-8 | Jun-9 | |
---|---|---|---|---|---|---|---|---|---|---|
May | Jun | |||||||||
26 | 30 | 31 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Akero Therapeutics Stock
Is Akero Therapeutics Stock a Buy?
- Akero Therapeutics share price is 52.49 while AKRO 8-day simple moving average is 49.59, which is a Buy signal.
- The stock price of AKRO is 52.49 while Akero Therapeutics 20-day SMA is 47.06, which makes it a Buy.
- Akero Therapeutics 50-day simple moving average is 44.02 while AKRO share price is 52.49, making it a Buy technically.
- AKRO stock price is 52.49 and Akero Therapeutics 200-day simple moving average is 40.68, creating a Buy signal.
AKRO Technical Analysis vs Fundamental Analysis
Buy
71
Akero Therapeutics (AKRO)
is a Buy
Is Akero Therapeutics a Buy or a Sell?
-
Akero Therapeutics stock is rated a Buy
The current Akero Therapeutics [AKRO] share price is $52.49. The Score for AKRO is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
Akero Therapeutics Stock Info
Market Cap:
2.9B
Price in USD:
52.49
Share Volume:
430.99K
Akero Therapeutics 52-Week Range
52-Week High:
54.88
52-Week Low:
7.52
Buy
71
Akero Therapeutics (AKRO)
is a Buy
Akero Therapeutics Share Price Forecast
-
What is the Akero Therapeutics stock price today?
The Akero Therapeutics stock price is 52.49 USD today. -
Will AKRO stock go up or go down?
Akero Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Akero Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Akero Therapeutics is not overvalued.
Is Akero Therapeutics Stock a Buy?
- Akero Therapeutics share price is 52.49 while AKRO 8-day exponential moving average is 50.10, which is a Buy signal.
- The stock price of AKRO is 52.49 while Akero Therapeutics 20-day EMA is 47.78, which makes it a Buy.
- Akero Therapeutics 50-day exponential moving average is 45.53 while AKRO share price is 52.49, making it a Buy technically.
- AKRO stock price is 52.49 and Akero Therapeutics 200-day simple moving average is 39.27, creating a Buy signal.
Fundamental Analysis of Akero Therapeutics
Is Akero Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.22 per share, and a decrease next year of $0.76 per share.
Technical Analysis of Akero Therapeutics
Should I short Akero Therapeutics stock?
- AKRO Moving Average Covergence Divergence (MACD) indicator is 1.96, suggesting Akero Therapeutics is a Buy
- Akero Therapeutics Relative Strength Index (RSI) is 67.52, which suggest Akero Therapeutics is overbought
- The Bollinger Bands (25) for Akero Therapeutics is (44.13 - 49.81), which suggest Akero Therapeutics is a Buy
- The Bollinger Bands (100) for Akero Therapeutics is (40.3 - 48.16), which suggest Akero Therapeutics is a Buy
* Akero Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.